1. Nicholls D.G., Ungerleider R.M., Spevak P.J. Hypoplastic left heart syndrome. In: Nicholls D.G., Ungerleider R.M. et al. (eds). Critical Heart Disease in Infants and Children, 2nd ed. Mosby, Philadelphia, 2006, pp 823 - 844.

2. Lev M. Pathologic anatomy and interrelationship of hypoplasia of the aortic tract complexes. Lab Invest 1952; 1: 61 - 70.

3. Tchervenkov C.I., Jacobs J.P., Weinberg P.M., et al. The nomenclature, definition and classification of hypoplastic left heart syndrome. Cardiol Young 2006; 16: 339 - 68.

4. Noonan J.A., Nadas A.S. The hypoplastic left heart syndrome. An analysis of 101 cases. Pediatr Clin North Am 1958; 5: 1029 - 1056.

5. Kirklin J.W., Barratt-Boyes B.G. Aortic atresia and other forms of hypoplastic left heart physiology. In: Kirklin J.W., Barratt-Boyes B.G. (eds). Cardiac Surgery. Fourth edition, 2013, pp 1780 - 1809.

6. Mahowald JM, Lucas RV Jr, Edwards JE. Aortic valvular atresia. Associated cardiovascular anomalies. Pediatr Cardiol 1982; 2: 99.

7. Jonas R.A. Hypoplastic left heart syndrome. In: Jonas R.A. (eds). Comprehensive Surgical Management of Congenital Heart Disease. Hodder Arnold, London, pp. 341 - 354

8. Izukawa T, Mullholland C, Rowe RD et al. Structural heart disease in newborn, changing profile: comparison of 1975 with 1965. Arch Dis Child 1979; 54: 281 - 285.

9. Scott D.J., Rigby M.L., Miller G.AH, Shinebourne E.A. The presentation of symptomatic heart disease in infancy based on 10 years' experience (1973 - 1982): implications for the provision of service. BrHeartJ 1984, 52: 248 - 257.

10. Бокерия Л.А., Шаталов К.В. Детская кардиохирургия: руководство для врачей. М.: НЦССХ им. А.Н. Бакулева 2016; стр. 684 - 700.

11. Hunter LE, Simpson JM. Prenatal screening for structural congenital heart disease. Nat Rev Cardiol. 2014; 11(6): 323 - 34.

12. Anderson R.H., Baker E.J., et al. Hypoplastic left heart syndrome. In: Anderson R.H. et al. (eds). Paediatric cardiology Anderson, 3rd ed. Churchill Livingstone, Philadelphia, 2010, pp. 625 - 645.

13. Mery C.M., Nieto R.M., De L.E., Morris S.A. et al. The Role of Echocardiography and Intracardiac Exploration in the Evaluation of Candidacy for Biventricular Repair in Patients With Borderline Left Heart Structures. Ann Thorac Surg. 2017 Mar; 103(3): 853 - 861.

14. McElhinney D.B., Vogel M., Benson C.B., Marshall A.C. et al. Assessment of left ventricular endocardial fibroelastosis in fetuses with aortic stenosis and evolving hypoplastic left heart syndrome. Am J Cardiol. 2010 Dec 15; 106(12): 1792 - 7.

15. Mahle WT, Weinberg PM, Rychik J. Can echocardiography predict the presence or absence of endocardial fibroelastosis in infants < 1 year of age with left ventricular outflow obstruction? Am J Cardiol 1998; 82(1): 122 - 4.

16. Kim HJ, Goo HW, Park SH, Yun TJ. Left ventricle volume measured by cardiac CT in an infant with a small left ventricle: a new and accurate method in determining uni- or biventricular repair. Pediatr Radiol. 2013 Jan; 43(2): 243 - 6

17. Dillman J.R., Dorfman A.L., Attili A.K., Agarwal P.P. et al. Cardiovascular magnetic resonance imaging of hypoplastic left heart syndrome in children. Pediatr Radiol. 2010 Mar; 40(3): 261 - 74. Theilen U., Shekerdemian L. The intensive care of infants with hypoplastic left heart syndrome. Arch Dis Child Fetal Neonatal Ed 2005; 90: P97 - 102.

18. Theilen U., Shekerdemian L. The intensive care of infants with hypoplastic left heart syndrome. Arch Dis Child Fetal Neonatal Ed 2005; 90: P97 - 102.

19. Feinstein J.A., Benson D.W., Dubin A.M., Cohen M.S. et al. Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll. Cardiol. 2012 Jan 3; 59(1 Suppl): S1 - 42.

20. Nakano T., Kado H., Tatewaki H., Hinokiyama K. et al. Surgical strategy and the results for hypoplastic left heart syndrome. Kyobu Geka. 2014 Apr; 67(4): 299 - 304.

21. Maeda Y., Yamagishi M., Miyazaki T., Yamamoto Y. et al. The treatment strategy for hypoplastic left heart syndrome. Kyobu Geka. 2014 Apr; 67(4): 305 - 9.

22. Sano S, Ishino K, Kawada M, et al. Right ventriclepulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2003; 126(2): 504 - 9.

23. Bacha EA, Daves S, Hardin J, et al. Single-ventricle palliation for high-risk neonates: the emergence of an alternative hybrid stage I strategy. J Thorac Cardiovasc Surg. 2006; 131(1): 163 - 171.

24. Caldarone CA, Benson L, Holtby H, Li J, Redington AN, Van Arsdell GS. Initial experience with hybrid palliation for neonates with single-ventricle physiology. Ann Thorac Surg. 2007; 84(4): 1294 - 300.

25. Galantowicz M, Cheatham JP, Phillips A, et al. Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg. 2008; 85(6): 2063 - 70.

26. Galantowicz M, Cheatham JP. Lessons learned from the development of a new hybrid strategy for the management of hypoplastic left heart syndrome. Pediatr Cardiol 2005; 26: 190 - 9. Erratum in: Pediatr Cardiol 2005; 26:307.

27. Hill SL, Galantowicz M, Cheatham JP. Emerging strategies in the treatment of hlhs: combined transcatheter & surgical techniques. Pediatr Cardiol Today 2003; 1: 1 - 4.

28. Almond CD, Thiagarajan RR, Piercey GE, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation 2009; 119: 717 - 27.

29. Boucek RJ, Chrisant M. Cardiac transplantation for hypoplastic left heart syndrome. Cardiol Young 2004; 14: 83 - 7.

30. Kirk R, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official pediatric heart transplantation report-2010. J Heart Lung Transplant 2010; 29: 1119 - 28.

31. Alsoufi B, Deshpande S, McCracken C, Kogon B, Vincent R, Mahle W, Kanter K. Results of heart transplantation following failed staged palliation of hypoplastic left heart syndrome and related single ventricle anomalies. Eur J Cardiothorac Surg. 2015 Nov; 48(5): 792 - 8.

32. Yasui H, Kado H, Nakano E, et al. Primary repair of interrupted aortic arch and severe aortic stenosis in neonates. J Thorac Cardiovasc Surg 1987; 93: 539 - 45.

33. Tchervenkov CI, Tahta Sa, Jutras LC, MJ. Biventricular Repair in Neonates with Hypoplastic Left Heart Complex. Ann Thorac Surg 1998; 66; 1350 - 7.

34. Бокерия Л.А., Подзолков В.П., Барышникова И.Ю., Симогаева Е.Б., Беришвили Д.О. Двухжелудочковая реконструкция после гибридного I этапа при обструктивных поражениях левого сердца. Детские болезни сердца и сосудов, 2013; 4: 32 - 36.

35. Калашников С.В., Беришвили Д.О. Влияние гипоплазии левых отделов сердца на возможность двухжелудочковой коррекции сложных врожденных пороков сердца периода новорожденности. Детские болезни сердца и сосудов. 2015; (4): 47 - 57.

36. Avitabile CM, Mercer-Rosa L, Ravishankar C, Rome JJ et. al. Experience with biventricular intervention for neonates with mitral valve abnormalities in the setting of critical left-side heart obstruction. Ann Thorac Surg. 2015 Mar; 99(3): 877 - 83.

37. Kanter KR, Kirshbom PM, Kogon BE; Biventricular repair with the Yasui operation (Norwood/Rastelli) for systemic outflow tract obstruction with two adequate ventricles; Ann Thorac Surg. 2012 Jun; 93(6).

38. Rogers BT, Msall ME, Buck GM, et al. Neurodevelopmental outcome of infants with hypoplastic left heart syndrome. J Pediatr 1995; 126: 496 - 8.

39. Kern JH, Hinton VJ, Nereo NE, Hayes CJ, Gersony WM. Early developmental outcome after the Norwood procedure for hypoplastic left heart syndrome. Pediatrics 1998; 102: 1148 - 52.

40. Martin BJ, De Villiers JI, Joffe AR, Bond GY, Acton BV et. al. Hypoplastic left heart syndrome is not associated with worse clinical or neurodevelopmental outcomes than other cardiac pathologies after the Norwood-Sano operation. Pediatr Cardiol. 2017 Jun; 38(5): 922 - 931.

41. Knirsch W, Liamlahi R, Dave H, Kretschmar O, Latal B. Neurodevelopmental Outcome of Children with Hypoplastic Left Heart Syndrome at One and Four Years of Age Comparing Hybrid and Norwood Procedure. Ann Thorac Cardiovasc Surg. 2016 Dec 20; 22(6): 375 - 377.

42. Raat H, Bonsel GJ, Essink-Bot ML, Landgraf JM, Gemke RJ. Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol 2002; 55: 67 - 76.

43. Garcia RU, Natarajan G, Walters HL, Delius RE, Aggarwal S. Acute kidney injury following first-stage palliation in hypoplastic left heart syndrome: hybrid versus Norwood palliation. Cardiol Young. 2018 Feb; 28(2): 261 - 268.

44. Goldstein BH, Goldstein SL, Devarajan P, Zafar F et al. First-stage palliation strategy for univentricular heart disease may impact risk for acute kidney injury. Cardiol Young. 2018 Jan; 28(1): 93 - 100.

45. Maller VV, Cohen HL. Neurosonography: Assessing the Premature Infant. Pediatr Radiol. 2017 Aug; 47(9): 1031 - 1045.

46. Barker GM, Forbess JM, Guleserian KJ, Nugent AW. Optimization of preoperative status in hypoplastic left heart syndrome with intact atrial septum by left atrial decompression and bilateral pulmonary artery bands. Pediatr Cardiol. 2014 Mar; 35(3): 479 - 84.

47. Gomide M, Furci B, Mimic B, Brown KL et al. Rapid 2-stage Norwood I for high-risk hypoplastic left heart syndrome and variants.J Thorac Cardiovasc Surg. 2013 Nov; 146(5): 1146 - 51; discussion 1151-2.

48. Mitani Y, Takabayashi S, Sawada H, Ohashi H, Hayakawa H, Ikeyama Y et al. Fate of the "opened" arterial duct: Lessons learned from bilateral pulmonary artery banding for hypoplastic left heart.

49. Stieh J, Fischer G, Scheewe J, Uebing A, P et al. Impact of preoperative treatment strategies on the early perioperative outcome in neonates with hypoplastic left heart syndrome J Thorac Cardiovasc Surg. 2006 May; 131(5): 1122 - 1129. e2.

50. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol (2002) 39: 1890 - 1900.

51. Grossfeld P, Ye M, Harvey R. Hypoplastic left heart syndrome: new genetic insights. J Am Coll Cardiol 2009; 53: 1072 - 4.

52. Sharland GK, Chita SK, Fagg NL, Anderson RH, Tynan M, Cook AC, et al. Left ventricular dysfunction in the fetus: relation to aortic valve anomalies and endocardial fibroelastosis. Br Heart J 1991; 66: 419.

53. Sedmera, D.; Cook, A.C.; Shirali, G.; McQuinn, T.C. Current issues and perspectives in hypoplasia of the left heart. Cardiol. Young 2005, 15, 56 - 72.

54. Krane, M.; Dressen, M.; Santamaria, G.; My, I.; Schneider, C.M.; Dorn, T.; Laue, S.; Mastantuono, E.; Berutti, R.; Rawat, H.; et al. Sequential Defects in Cardiac Lineage Commitment and Maturation Cause

55. Bardo DM, Frankel DG, Applegate KE, Murphy DJ, Saneto RP. Hypoplastic left heart syndrome. Radiographics. 2001 May - Jun; 21(3): 705 - 17.

56. Norwood WI. Hypoplastic left heart syndrome. Cardiol Clin 1989; 7: 377 - 385.

57. Norwood WI. Hypoplastic left heart syndrome. Ann Thorac Surg 1991; 52: 688 - 695.

58. Kritzmire SM, Cossu AE. Hypoplastic Left Heart Syndrome. 2023 Apr 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan.

59. Metcalf MK, Rychik J. Outcomes in Hypoplastic Left Heart Syndrome. Pediatr Clin North Am. 2020 Oct; 67(5): 945 - 962.

60. Rychik J, Rome JJ, Collins MH, et al. The hypoplastic left heart syndrome with intact atrial septum: atrial morphology, pulmonary vascular histopathology and outcome. J Am Coll Cardiol 1999; 34: 554 - 60.

61. Glatz JA, Tabbutt S, Gaynor JW, et al. Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis. Ann Thorac Surg 2007; 84: 1633 - 8.

62. Saxena A, Relan J, Agarwal R, Awasthy N, Azad S, Chakrabarty M. et all. Indian guidelines for indications and timing of intervention for common congenital heart diseases: Revised and updated consensus statement of the Working group on management of congenital heart diseases. Ann Pediatr Cardiol. 2019 Sep - Dec; 12(3): 254 - 286.

63. DaCruz EM, Ivy D, Jaggers J Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. London, Springer London, 2014. DOI: 10.1007/978-1-4471-4619-3.

64. Feinstein JA, Benson DW, Dubin AM, Cohen MS, Maxey DM et al. Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll Cardiol. 2012 Jan 3; 59(1 Suppl): S1 - 42. Erratum in: J Am Coll Cardiol. 2012 Jan 31; 59(5): 544.

65. Roeleveld PP, Axelrod DM, Klugman D, Jones MB, Chanani NK, Rossano JW, Costello JM. Hypoplastic left heart syndrome: from fetus to Fontan. Cardiol Young. 2018 Nov; 28(11): 1275 - 1288.

66. Liu MY, Zielonka B, Snarr BS, et al. Longitudinal assessment of outcome from prenatal diagnosis through fontan operation for over 500 fetuses with single ventricle-type congenital heart disease: the philadelphia fetus-to-fontan cohort study. J Am Heart Assoc 2018; 7: e009145.

67. Ohye RG, Schranz D, D'Udekem Y. Current therapy for hypoplastic left heart syndrome and related single ventricle lesions. Circulation 2016; 134: 1265 - 1279.

68. Morris SA, Ethen MK, Penny DJ, et al. Prenatal diagnosis, birth location, surgical center, and neonatal mortality in infants with hypoplastic left heart syndrome. Circulation 2014; 129: 285 - 292.

69. Share DA, Campbell DA, Birkmeyer N, Prager RL, Gurm HS, Moscucci M, Udow-Phillips M, Birkmeyer JD. How a regional collaborative of hospitals and physicians in Michigan cut costs and improved the quality of care. Health Aff (Millwood). 2011; 30: 636 - 645.

70. Mahle, WT.; Nicolson, S.; Shekerdemian, LS.; Gaies, MG.; Witte, MK.; Lee, EK.; Goldsworthy, M.; Stark, P.; Burns, KM.; Scheurer, MA.; Cooper, DS.; Thiagarajan, R.; Sivarajan, B.; Hollenbeck-Pringle, D.; Colan, S. American Heart Association Scientific Sessions 2015. Orlando, Florida: Nov 10. 2015 Utilizing a Collaborative Learning Model to Decrease Length of Postoperative Ventilation Following Infant Heart Surgery.

71. Pasquali SK, Ohye RG, Lu M, Kaltman J, Caldarone CA, Pizarro C, Dunbar-Masterson C, Gaynor JW, Jacobs JP, Kaza AK, Newburger J, Rhodes JF, Scheurer M, Silver E, Sleeper LA, Tabbutt S, Tweddell J, Uzark K, Wells W, Mahle WT, Pearson GD, for the Pediatric Heart Network Investigators. Variation in perioperative care across centers for infants undergoing the Norwood procedure. J Thorac Cardiovasc Surg. 2012; 144: 915 - 921.

72. Graham EM, Bradley SM, Atz AM. Preoperative management of hypoplastic left heart syndrome. Expert Opin Pharmacother. 2005 May; 6(5): 687 - 93.

73. abbutt S, Ramamoorthy C, Montenegro LM, et al. Impact of inspired gas mixtures on preoperative infants with hypoplastic left heart syndrome during controlled ventilation. Circulation 2001; 104: I-159-64.

74. Gatelli IF, Vitelli O, Chiesa G, De Rienzo F, Martinelli S. Noninvasive Cardiac Output Monitoring in Newborn with Hypoplastic Left Heart Syndrome. Am J Perinatol. 2020 Sep; 37(S02): S54 - S56.

75. ElHassan NO, Tang X, Gossett J, Zakaria D, Ross A, Kona SK, Prodhan P. Necrotizing Enterocolitis in Infants with Hypoplastic Left Heart Syndrome Following Stage 1 Palliation or Heart Transplant. Pediatr Cardiol. 2018 Apr; 39(4): 774 - 785.

76. Javed R, Cetta F, Said SM, Olson TM, O"Leary PW, Qureshi MY. Hypoplastic Left Heart Syndrome: An Overview for Primary Care Providers. Pediatr Rev. 2019 Jul; 40(7): 344 - 353.

77. Tran NN, Tran M, Lemus RE, Woon J, Lopez J, Dang R, Votava-Smith JK. Preoperative Care of Neonates With Congenital Heart Disease. Neonatal Netw. 2022 Jul 1; 41(4): 200 - 210.

78. Johnson B, Mussatto K, Uhing M, Zimmerman H, Tweddell J, Ghanayem N. Variability in the preoperative management of infants with hypoplastic left heart syndrome. Pediatr Cardiol 2008; 29: 515 - 20.

79. M, Sacharczuk J, Mleczko M, Skalski JH, Mroczek T. The effect of prenatal diagnosis on antibiotic therapy in neonates with hypoplastic left heart syndrome. Antibiotics in prenatally diagnosed patients with HLHS. Folia Med Cracov. 2019; 59(2): 35 - 44.

80. Webb G.D., Smallhorn J.F., Th errien J., Redington A.N.: Congenital heart disease. In: Bonow R.O., Mann D.L., Zipes D.P., Libby P., eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia, PA: Saunders Elsevier; 2011: chap. 65.

81. Fukushima Y, Baba K, Kondo M, Kurita Y, Eitoku T, Shigemitsu Y, Hirai K, Tsukahara H, Iwasaki T, Kasahara S, Kotani Y, Otsuki S. Balloon atrial septostomy in hypoplastic left heart syndrome with restrictive atrial septum. Pediatr Int. 2019 Apr; 61(4): 339 - 344.

82. Vlahos AP, Lock JE, McElhinney DB, van der Velde ME. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: outcome after neonatal transcatheter atrial septostomy. Circulation. 2004 May 18; 109(19): 2326 - 30.

83. Gossett JG, Rocchini AP, Lloyd TR, Graziano JN. Catheter-based decompression of the left atrium in patients with hypoplastic left heart syndrome and restrictive atrial septum is safe and effective. Catheter Cardiovasc Interv. 2006 Apr; 67(4): 619 - 24.

84. Hoque T, Richmond M, Vincent JA, Bacha E, Torres A. Current outcomes of hypoplastic left heart syndrome with restrictive atrial septum: A single-center experience. Pediatr. Cardiol. 2013; 34: 1181 - 9.

85. Hansen JH, Petko C, Bauer G, Voges I, Kramer H-H, Scheewe J. Fifteen-year single-center experience with the Norwood operation for complex lesions with single-ventricle physiology compared with hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2012; 144: 166 - 172.

86. Tabbutt S, Ghanayem N, Ravishankar C, Sleeper LA, Cooper DS, Frank DU, Lu M, Pizarro C, Frommelt P, Goldberg CS, Graham EM, Krawczeski CD, Lai WW, Lewis A, Kirsh JA, Mahony L, Ohye RG, Simsic J, Lodge AJ, Spurrier E, Stylianou M, Laussen P, Investigators PHN. Risk factors for hospital morbidity and mortality after the Norwood procedure: A report from the Pediatric Heart Network Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg. 2012; 144: 882 - 895.

87. Ghanayem NS, Tweddell JS, Hoffman GM, Mussatto K, Jaquiss RD. Optimal timing of the second stage of palliation for hypoplastic left heart syndrome facilitated through home monitoring, and the results of early cavopulmonary anastomosis. Cardiol Young. 2006 Feb; 16 Suppl 1: 61 - 6.

88. de Leval MR, Deanfield JE. Four decades of Fontan palliation. Nat Rev Cardiol. 2010; 7: 520 - 527.

89. d'Udekem Y, Iyengar AJ, Galati JC, Forsdick V, Weintraub RG, Wheaton GR, Bullock A, Justo RN, Grigg LE, Sholler GF, Hope S, Radford DJ, Gentles TL, Celermajer DS, Winlaw DS. Redefining Expectations of Long-Term Survival After the Fontan Procedure: Twenty-Five Years of Follow-Up From the Entire Population of Australia and New Zealand. Circulation. 2014; 130: S32 - S38.

90. Pundi KN, Johnson JN, Dearani JA, Pundi KN, Li Z, Hinck CA, Dahl SH, Cannon BC, O'Leary PW, Driscoll DJ, Cetta F. 40-Year Follow-Up After the Fontan Operation. J Am Coll Cardiol. 2015; 66: 1700 - 1710.

91. Anderson PAW, Sleeper LA, Mahony L, Colan SD, Atz AM, Breitbart RE, Gersony WM, Gallagher D, Geva T, Margossian R, McCrindle BW, Paridon S, Schwartz M, Stylianou M, Williams RV, Clark BJ, Pediatric Heart Network Investigators. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol. 2008; 52: 85 - 98.

92. Jaquiss RDB, Ghanayem NS, Hoffman GM, et al. Early cavopul-monary anastomosis in very young infants after the Norwood procedure: impact on oxygenation, resource utilization, and mortality. J Thorac Cardiovasc Surg 2004; 127: 982 - 9.

93. Salazar J, Zafar F, Siddiqui K. Fenestration during Fontan palliation: now the exception instead of the rule. J Thorac Cardiovasc Surg 2010; 140: 129 - 36.

94. Robbers-Visser D, Miedema M, Nijveld A, et al. Results of staged total cavopulmonary connection for functionally univentricular hearts; comparison of intra-atrial lateral tunnel and extracardiac conduit. Eur J Cardiothorac Surg 2010; 37: 934 - 41.

95. Fiore AC, Turrentine M, Rodefeld M, et al. Fontan operation: a comparison of lateral tunnel with extracardiac conduit. Ann Thorac Surg 2007; 83: 622 - 30.

96. Rai V, M, M, Skalski J. Hypoplastic left heart syndrome [HLHS]: treatment options in present era. Indian J Thorac Cardiovasc Surg. 2019 Apr; 35(2): 196 - 202.

97. Galantowicz M, Yates AR. Improved outcomes with the comprehensive stage 2 procedure after an initial hybrid stage 1. J Thorac and Cardiovasc Surg. 2016; 151: 424 - 429.

98. Yerebakan C, Valeske K, Elmontaser H, U, Mueller M, Thul J, Mann V, Latus H, Villanueva A, Hofmann K, Schranz D, Akintuerk H. Hybrid therapy for hypoplastic left heart syndrome: Myth, alternative, or standard? J Thorac Cardiovasc Surg. 2016; 151: 1112 - 1123.

99. Nassar MS, Narayan SA, Nyman A, Salih C, Austin CB, Anderson D, Hussain T. Second stage after initial hybrid palliation for hypoplastic left heart syndrome: Arterial or venous shunt? J Thorac Cardiovasc Surg. 2015 Aug; 150(2): 350 - 7.

100. Akintuerk H, Michel-Behnke I, Valeske K, et al. Stenting of the arterial duct and banding of the pulmonary arteries: basis for combined Norwood stage I and II repair in hypoplastic left heart. Circulation 2002; 105: 1099 - 103.

101. Guidelines for the Management of Congenital Heart Diseases. Cardiology in the Young (2017), 27 (Suppl. 3), S1 - S105.

102. .Vari D, Xiao W, Behere S, Spurrier E, Tsuda T, Baffa JM. Low-dose prostaglandin E1 is safe and effective for critical congenital heart disease: is it time to revisit the dosing guidelines? Cardiol Young. 2021 Jan; 31(1): 63 - 70.

103. .Yucel IK, Cevik A, Bulut MO, R, Demir , Erdem A, Celebi A. Efficacy of very low-dose prostaglandin E1 in duct-dependent congenital heart disease. Cardiol Young. 2015 Jan; 25(1): 56 - 62.

104. Khalil M, Jux C, Rueblinger L, Behrje J, Esmaeili A, Schranz D. Acute therapy of newborns with critical congenital heart disease. Transl Pediatr. 2019 Apr; 8(2): 114 - 126.

105. Masarone D, Valente F, Rubino M, Vastarella R, Gravino R., Rea A, et al. Pediatric Heart Failure: A Practical Guide to Diagnosis and Management. Pediatr Neonatol. 2017 Aug; 58(4): 303 - 312.

106. Kantor PF, Lougheed J, Dancea A, McGillion M, Barbosa N, Chan C, et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Can J Cardiol. 2013 Dec; 29(12): 1535 - 52.

107. Lechner E, Moosbauer W, Pinter M, Mair R, Tulzer G. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate. Pediatr Crit Care Med. 2007 Jan; 8(1): 61 - 3.

108. Namachivayam P, Crossland DS, Butt WW, Shekerdemian LS. Early experience with Levosimendan in children with ventricular dysfunction. Pediatr Crit Care Med. 2006 Sep; 7(5): 445 - 8.

109. Yu XR, Xu N, Huang ST, Zhang QL, Wang ZC, Cao H, Chen Q. Effects of different oral care strategies on postoperative pneumonia in infants with mechanical ventilation after cardiac surgery: a prospective randomized controlled study. Transl Pediatr. 2021 Feb; 10(2): 359 - 365.

110. Tural-Kara T. et al. Underlying Diseases and Causative Microorganisms of Recurrent Pneumonia in Children: A 13-Year Study in a University Hospital//Journal of tropical pediatrics. - 2019. - Т. 65. - N. 3. - С. 224 - 230.

111. Shi S. S. et al. Perioperative risk factors for prolonged mechanical ventilation following cardiac surgery in neonates and young infants. Chest. - 2008. - Т. 134. - N. 4. - С. 768 - 774.

112. Norwood WI, Kirklin JK, Sanders SP. Hypoplastic left heart syndrome: experience with palliative surgery. Am J Cardiol. 1980; 45: 87 - 91.

113. Norwood WI, Lang P, Casteneda AR, Campbell DN. Experience with operations for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 1981; 82: 511 - 519.

114. Sano S, Ishino K, Kawada M, Honjo O. Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annual. 2004; 7: 22 - 31.

115. Gibbs JL, Wren C, Watterson KG, Hunter S, Hamilton JR. Stenting of the arterial duct combined with banding of the pulmonary arteries and atrial septectomy or septostomy: a new approach to palliation for the hypoplastic left heart syndrome. Br Heart J. 1993; 69: 551 - 555.

116. Schranz D, Bauer A, Reich B, Steinbrenner B, Recla S, Schmidt D, Apitz C, Thul J, Valeske K, Bauer J, M, Jux C, Michel-Behnke I, H. Fifteen-year single center experience with the "Giessen Hybrid" approach for hypoplastic left heart and variants: current strategies and outcomes. Pediatr Cardiol. 2015; 36: 365 - 373.

117. Schranz D, Voelkel NF. "Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld. Eur J Pediatr. 2016; 175: 445 - 455.

118. Sakurai T, Kado H, Nakano T, Hinokiyama K, Shiose A, Kajimoto M, Joo K, Ueda Y. Early results of bilateral pulmonary artery banding for hypoplastic left heart syndrome. Eur J Cardiothorac Surg. 2009 Dec; 36(6): 973 - 9.

119. Pizarro C, Derby CD, Baffa JM, Murdison KA, Radtke WA. Improving the outcome of high-risk neonates with hypoplastic left heart syndrome: hybrid procedure or conventional surgical palliation? Eur J Cardiothorac Surg 2008; 33: 613 - 8.

120. Schulz A, Sinzobahamvya N, Cho MY, W, Miera O, Redlin M, Ovroutski S, Photiadis J. Bilateral Pulmonary Artery Banding before Norwood Procedure: Survival of High-Risk Patients. Thorac Cardiovasc Surg. 2020 Jan; 68(1): 30 - 37.

121. Guleserian KJ, Barker GM, Sharma MS, et al. Bilateral pulmonary artery banding for resuscitation in high-risk, single-ventricle neonates and infants: a single-center experience. J Thorac Cardiovasc Surg 2013; 145(01): 206 - 213, discussion 213 - 214.

122. Hirata Y, Miyata H, Hirahara N, Murakami A, Kado H, Sakamoto K, Sano S, Takamoto S. Long-Term Results of Bilateral Pulmonary Artery Banding Versus Primary Norwood Procedure. Pediatr Cardiol. 2018 Jan; 39(1): 111 - 119.

123. Kitahori K, Murakami A, Takaoka T, Takamoto S, Ono M. Precise evaluation of bilateral pulmonary artery banding for initial palliation in high-risk hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2010 Nov; 140(5): 1084 - 91.

124. Sakurai T, Sakurai H, Yamana K, Nonaka T, Noda R, Otsuka R, Osawa T. Expectations and limitations after bilateral pulmonary artery banding. Eur J Cardiothorac Surg. 2016 Oct; 50(4): 626 - 631.

125. Калашников С.В., Бокерия Л.А., Нефедова И.Е. Двухжелудочковая коррекция врожденных пороков сердца у пациентов с гипоплазией структур левых отделов сердца: морфометрические и гемодинамические критерии. Детские болезни сердца и сосудов. 2020; 17 (1): 25 - 37.

126. Licht DJ, Shera DM, Clancy RR, Wernovsky G, Montenegro LM, Nicolson SC, Zimmerman RA, Spray TL, Gaynor JW, Vossough A. Brain maturation is delayed in infants with complex congenital heart defects. J Thorac Cardiovasc Surg. 2009; 137: 536 - 537.

127. Knirsch WL, Liamlahi R, Hug MI, Hoop R, von Rhein M, R, Kretschmar O, Latal B. Mortality and neurodevelopmental outcome at 1 year of age comparing hybrid and Norwood procedures. Eur J Cardiothorac Surg. 2012; 42:33 - 39.

128. Rudd NA, Frommelt MA, Tweddell JS, Hehir DA, Mussatto KA, Frontier KD, Slicker JA, Bartz PJ, Ghanayem NS. Improving interstage survival after Norwood operation: outcomes from 10 years of home monitoring. J Thorac Cardiovasc Surg. 2014; 148: 1540 - 1547.

129. McCrindle BW, Williams RV, Mitchell PD, Hsu DT, Paridon SM, Atz AM, Li JS, Newburger JW, for the Pediatric Heart Network Investigators. Relationship of patient and medical characteristics to health status in children and adolescents after the Fontan procedure. Circulation. 2006; 113: 1123 - 1129.

130. Anderson PAW, Breitbart RE, McCrindle BW, Sleeper LA, Atz AM, Hsu DT, Lu M, Margossian R, Williams RV. The Fontan Patient: Inconsistencies in Medication Therapy Across Seven Pediatric Heart Network Centers. Pediatr Cardiol. 2010; 31: 1219 - 1228.

131. Trivedi B, Smith PB, Barker PCA, Jaggers J, Lodge AJ, Kanter RJ. Arrhythmias in patients with hypoplastic left heart syndrome. Am Heart J. 2011; 161: 138 - 144.

132. Idorn L, Juul K, Jensen AS, Hanel B, Nielsen KG, Andersen H, Reimers JI, KE, L. Arrhythmia and exercise intolerance in Fontan patients: current status and future burden. Int J Cardiol. 2013; 168: 1458 - 1465.

133. Alsaied T, Alsidawi S, Allen CC, Faircloth J, Palumbo JS, Veldtman GR. Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis. Heart. 2015; 101: 1731 - 1737.

134. Monagle P, Cochrane A, Roberts R, Manlhiot C, Weintraub R, Szechtman B, Hughes M, Andrew M, McCrindle BW, Fontan Anticoagulation Study Group. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol. 2011; 58: 645 - 651.

135. Thacker D, Patel A, Dodds K, Goldberg DJ, Semeao E, Rychik J. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg. 2010; 89: 837 - 842.

136. Anne P, Du W, Mattoo TK, Zilberman MV. Nephropathy in patients after Fontan palliation. Int J Cardiol. 2009; 132: 244 - 247.

137. Van Hare GF, Ackerman MJ, Evangelista J-AK, Kovacs RJ, Myerburg RJ, Shafer KM, Warnes CA, Washington RL, American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and the American College of Cardiology. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015; 132: e281 - 91.

138. Jonas R, Jonas RA. Cardiac surgery and neurological injury in children. Heart Lung Circ. 2000; 9: 16 - 22.

139. Hellmund A, Berg C, Herberg U, Geipel A, Kempe A, Gembruch U. Levoatrial cardinal vein in a series of five prenatal cases with hypoplastic left heart syndrome and intact atrial septum. Ultraschall in Med 2017; 38: 206 - 11.

140. Atz AM, Travison TG, Williams IA, Pearson GD, Laussen PC, Mahle WT et al. Prenatal diagnosis and risk factors for preoperative death in neonates with single right ventricle and systemic outflow obstruction: screening data from the Pediatric Heart Network Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg 2010; 140: 1245 - 50.

141. Donofrio MT, Moon-Grady AJ, Hornberger LK, Copel JA, Sklansky MS, Abuhamad A et al.; American Heart Association Adults with Congenital Heart Disease Joint Committee of the Council on Cardiovascular Disease in the Young and Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Council on Cardiovascular and Stroke Nursing. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation 2014; 129: 2183 - 242.

142. Herberg U, Berg C, Geipel A, Gembruch U, Breuer J. Foetal therapy: what works? Closed interatrial septum. Cardiol Young 2014; 24: 47 - 54.

143. Vogel M, McElhinney DB, Wilkins-Haug LE, Marshall AC, Benson CB, Juraszek AL et al. Aortic stenosis and severe mitral regurgitation in the fetus resulting in giant left atrium and hydrops: pathophysiology, outcomes, and preliminary experience with pre-natal cardiac intervention. J Am Coll Cardiol 2011; 57: 348 - 55.

144. Barron DJ, Kilby MD, Davies B, Wright JGC, Jones TJ, Brawn WJ. Hypoplastic left heart syndrome. Lancet 2009; 374: 551 - 64.

145. Alphonso N, Angelini A, Barron DJ, Bellsham-Revell H, Blom NA, Brown K, Davis D, Duncan D, Fedrigo M, Galletti L, Hehir D, Herberg U, Jacobs JP, Januszewska K, Karl TR; (Chaiman HLHS Guidelines Task Force); Malec E, Maruszewski B, Montgomerie J, Pizzaro C, Schranz D, Shillingford AJ, Simpson JM. Guidelines for the management of neonates and infants with hypoplastic left heart syndrome: The European Association for Cardio-Thoracic Surgery (EACTS) and the Association for European Paediatric and Congenital Cardiology (AEPC) Hypoplastic Left Heart Syndrome Guidelines Task Force. Eur J Cardiothorac Surg. 2020 Sep 1; 58(3): 416 - 499.

146. Egbe A, Uppu S, Lee S, Stroustrup A, Ho D, Srivastava S. Temporal variation of birth prevalence of congenital heart disease in the United States. Congenit Heart Dis 2015; 10: 43 - 50.

147. Sathanandam SK, Philip R, Gamboa D, Van Bergen A, Ilbawi MN, Knott-Craig C et al. Management of hypoplastic left heart syndrome with intact atrial septum: a two-centre experience. Cardiol Young 2016; 26: 1072 - 81.

148. Arai S, Fujii Y, Kotani Y, Kuroko Y, Kasahara S, Sano S. Surgical outcome of hypoplastic left heart syndrome with intact atrial septum. Asian Cardiovasc Thorac Ann 2015; 23: 1034 - 8.

149. Gellis L, Drogosz M, Lu M, Sleeper LA, Cheng H, Allan C et al. Echocardiographic predictors of neonatal illness severity in fetuses with critical left heart obstruction with intact or restrictive atrial septum. Prenat Diagn 2018; 38: 788 - 94.

150. Saul D, Degenhardt K, Iyoob SD, Surrey LF, Johnson AM, Johnson MP et al. Hypoplastic left heart syndrome and the nutmeg lung pattern in utero: a cause and effect relationship or prognostic indicator? Pediatr Radiol 2016; 46: 483 - 9.

151. Jacobs JP. Hypoplastic Left Heart Syndrome: Definition, Morphology, and Classification. World Journal for Pediatric and Congenital Heart Surgery. 2022; 13(5): 559 - 564.

152. Yagi H, Liu X, Gabriel GC, Wu Y, Peterson K, Murray SA et al. The genetic landscape of hypoplastic left heart syndrome. Pediatr Cardiol 2018; 39: 1069 - 81.

153. Perry DJ, Mullen CR, Carvajal HG, Brar AK, Eghtesady P. Familial screening for left-sided congenital heart disease: what is the evidence? What is the cost? Diseases 2017; 5: 29.

154. Zakaria D, Tang X, Bhakta R, ElHassan NO, Prodhan P. Chromosomal abnormalities affect the surgical outcome in infants with hypoplastic left heart syndrome: a large cohort analysis. Pediatr Cardiol 2018; 39: 11 - 18.

155. Gordon BM, Rodriguez S, Lee M, Chang R-K. Decreasing number of deaths of infants with hypoplastic left heart syndrome. J Pediatr 2008; 153: 354 - 8.

156. Peterson AL, Quartermain MD, Ades A, Khalek N, Johnson MP, Rychik J. Impact of mode of delivery on markers of perinatal hemodynamics in infants with hypoplastic left heart syndrome. J Pediatr 2011; 159: 64 - 9.

157. Costello JM, Pasquali SK, Jacobs JP, He X, Hill KD, Cooper DS et al. Gestational age at birth and outcomes after neonatal cardiac surgery: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. Circulation 2014; 129: 2511 - 17.

158. Marx GR, Shirali G, Levine JC, Guey LT, Cnota JF, Baffa JM et al. Multicenter study comparing shunt type in the Norwood procedure for single-ventricle lesions: three-dimensional echocardiographic analysis. Circ Cardiovasc Imaging 2013; 6: 934 - 42.

159. Gorbatykh A, Manannikov D, Ivanilova A, Averkin I, Zubarev D, et al. A clinical case of successful palliative endovascular treatment of a patient with a single ventricle, mitral valve atresia, an intact atrial septum and persistent cardinal vein. Egypt Heart J. 2023 May 18; 75(1): 41.

160. Wyckoff MH, Aziz K, Escobedo MB, Kapadia VS, Kattwinkel J, Perlman JM et al. Part 13: neonatal resuscitation: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2015; 132: S543 - 60.

161. Mercer-Rosa L, Goldberg DJ. Prognostic value of serial echocardiography in hypoplastic left heart syndrome: smaller hearts, better results. Circ Cardiovasc Imaging 2018; 11: e008006.

162. Fraser CD, Carberry KE. Congenital heart disease. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL (eds). Sabiston Textbook of Surgery, 19th edn. Philadelphia: Elsevier, Saunders, 2012, 1611 - 49.

163. Fricker FJ. Hypoplastic left heart syndrome: diagnosis and early management. NeoReviews 2008; 9: e253 - 61.

164. Slicker J, Hehir DA, Horsley M, Monczka J, Stern KW, Roman B et al. Nutrition algorithms for infants with hypoplastic left heart syndrome; birth through the first interstage period. Congenit Heart Dis 2013; 8: 89 - 102.

165. Carpenito K-R, Prusinski R, Kirchner K, Simsic J, Miao Y, Luce W et al. Results of a feeding protocol in patients undergoing the hybrid procedure. Pediatr Cardiol 2016; 37: 852 - 9.

166. Iannucci GJ, Oster ME, Mahle WT. Necrotising enterocolitis in infants with congenital heart disease: the role of enteral feeds. Cardiol Young 2013; 23: 553 - 9.

167. Akkinapally S, Hundalani SG, Kulkarni M, Fernandes CJ, Cabrera AG, Shivanna B et al. Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions. Cochrane Database Syst Rev 2018; 2: CD011417.

168. Karamlou T, Najm HK. Evolution of care pathways for babies with hypoplastic left heart syndrome: integrating mechanistic and clinical process investigation, standardization, and collaborative study. J Thorac Dis. 2020 Mar; 12(3): 1174 - 1183.

169. Gaynor JW, Mahle WT, Cohen MI, Ittenbach RF, DeCampli WM, Steven JM et al. Risk factors for mortality after the Norwood procedure. Eur J Cardiothorac Surg 2002; 22: 82 - 9.

170. Tabbutt S, Dominguez TE, Ravishankar C, Marino BS, Gruber PJ, Wernovsky G et al. Outcomes after the stage I reconstruction comparing the right ventricular to pulmonary artery conduit with the modified Blalock Taussig shunt. Ann Thorac Surg 2005; 80: 1582 - 90; discussion 1590-1.

171. Chowdhury SM, Graham EM, Atz AM, Bradley SM, Kavarana MN, Butts RJ. Validation of a simple score to determine risk of hospital mortality after the Norwood procedure. Semin Thorac Cardiovasc Surg 2016; 28: 425 - 33.

172. Azakie T, Merklinger SL, McCrindle BW, Van Arsdell GS, Lee KJ, Benson LN et al. Evolving strategies and improving outcomes of the modified Norwood procedure: a 10-year single-institution experience.

173. McGuirk SP, Stickley J, Griselli M, Stumper OF, Laker SJ, Barron DJ et al. Risk assessment and early outcome following the Norwood procedure for hypoplastic left heart syndrome. Eur J Cardiothorac Surg 2006; 29: 675 - 81.

174. Национальные рекомендации по ведению детей с врожденными пороками сердца. Ред. Л.А. Бокерия. М., 2014.

175. Постановление Главного государственного санитарного врача РФ от 28 января 2021 г. N 4 "Об утверждении санитарных правил и норм СанПиН 3.3686-21 "Санитарно-эпидемиологические требования по профилактике инфекционных болезней".

176. Приказ Минздрава РФ от 20 октября 2020 г. N 1134н "Об утверждении порядка медицинского обследования реципиента, проведения проб на индивидуальную совместимость, включая биологическую пробу, при трансфузии донорской крови и (или) ее компонентов"

177. Аксельрод Б.А., Балашова Е.Н., Баутин А.Е., Баховадинов Б.Б., Бирюкова Л.С. и др. Клиническое использование эритроцитсодержащих компонентов донорской крови. Гематология и трансфузиология. 2018; 63(4): 372 - 435.

178. Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, U, Vesely SK. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl): e737S - e801S.

179. Купряшов А.А., Токмакова К.А. Нарушения системы свертывания крови в сердечно-сосудистой хирургии. В кн.: Система гемостаза. Теоретические основы и клиническая практика: Национальное руководство/О.А. Рукавицын, С.В. Игнатьев, А.Г. Румянцев [и др.]. Москва: Общество с ограниченной ответственностью Издательская группа "ГЭОТАР-Медиа", 2024. 944 с. ISBN 978-5-9704-8497-5.

180. Bharucha T, Viola N. The tricuspid valve in hypoplastic left heart syndrome: Echocardiography provides insight into anatomy and function. Front Pediatr. 2023 Mar 27; 11: 1145161

181. Mart CR, Eckhauser AW, Murri M, Su JT. A systematic method for using 3D echocardiography to evaluate tricuspid valve insufficiency in hypoplastic left heart syndrome. Ann Pediatr Cardiol. (2014) 7(3): 193.

182. Rao S, Challapudi G, Chellu N, Bhimani S, Prieto L, Komarlu R. Selective Coronary Artery Angiography in Hypoplastic Left Heart Syndrome. J Invasive Cardiol. 2020 Dec; 32(12): E326 - E330.

183. Murni IK, MacLaren G, Morrow D, et al. Perioperative infections in congenital heart disease. Cardiol Young 2017; 27(S6): S14e21.

184. Wang X, Li S, Huo D, et al. Nosocomial Infections After Pediatric Congenital Heart Disease Surgery: Data from National Center for Cardiovascular Diseases in China. Infect Drug Resist. 2024; 17: 1615 - 1623.

185. Anderson BR, Ciarleglio AJ, Krishnamurthy G, et al. Neonatal hypoplastic left heart syndrome: effects of bloodstream infections on outcomes and costs. Ann Thorac Surg. 2015; 99(5): 1648 - 54.

186. Yu X, Chen M, Liu X. et al. Risk factors of nosocomial infection after cardiac surgery in children with congenital heart disease. BMC Infect Dis. 2020; 20(1): 64. doi: 10.1186/s12879-020-4769-6.

187. Rallis, D.; Giapros, V.; Serbis, A. et al. Fighting Antimicrobial Resistance in Neonatal Intensive Care Units: Rational Use of Antibiotics in Neonatal Sepsis. Antibiotics 2023, 12, 508.

188. Crellen T., Turner P., Pol S., et al. Transmission dynamics and control of multidrug-resistant Klebsiella pneumoniae in neonates in a developing country. Elife. 2019; 3(8): e50468.

189. Guidelines for the prevention and control of carbapenemresistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Geneva: World Health Organization; 2017. Available at: https://apps.who.int/iris/handle/10665/259462.

190. Lekmanov A.U., Mironov P.I., Aleksandrovich Yu.S., Azovskij D.K., Popov D.A., Pshenisnov K.V., et al. Sepsis in children: Federal clinical guideline (draft). Russian journal of pediatric surgery anesthesia and intensive care. 2021; 11(2): 241 - 292. Russian. (Лекманов А.У., Миронов П.И., Александрович Ю.С., Азовский Д.К., Попов Д.А., Пшениснов К.В. и соавт. Сепсис у детей: федеральные клинические рекомендации (проект). Российский вестник детской хирургии, анестезиологии и реаниматологии. 2021; 2: 241 - 292.).

191. Lee Y.Q., Ahmad K.A., Velayuthan R.D., et al. Clonal relatedness in the acquisition of intestinal carriage and transmission of multidrug resistant (MDR) Klebsiella pneumoniae and Escherichia coli and its risk factors among preterm infants admitted to the neonatal intensive care unit (NICU). Pediatr Neonatol. 2021; 62(2): 129137.

192. Sakai AM, Iensue TNAN, Pereira KO, et al. Colonization by multidrug-resistant microorganisms of hospitalized newborns and their mothers in the neonatal unit context. J Infect Dev Ctries. 2020, 31; 14(7): 765 - 771.

193. Попов Д.А. и соавт. Колонизация слизистых оболочек "проблемной" микрофлорой и этиология послеоперационных инфекционных осложнений у детей первого года жизни с врожденными пороками сердца. Клиническая микробиология и антимикробная химиотерапия. 2022; 2: 139 - 146.

194. Организация и проведение микробиологического мониторинга в медицинских организациях: Методические рекомендации: Министерство здравоохранения Российской Федерации, ФГБУ "НМИЦ АГП им. В.И. Кулакова" Минздрава России, 2024. - 38 с.

195. Голухова Е.З., Ким А.И., Завалихина Т.В., Нефедова И.Е. и др. Анализ оказания медицинской помощи детям с врожденными пороками сердца в Российской Федерации и предпосылки к созданию регистра в современную эру цифровых медицинских информационных систем. Креативная кардиология. 2023; 17 (3): 315 - 21.

196. Голухова Е.З., Ким А.И., Завалихина Т.В., Нефедова И.Е., Калашников С.В. Резервы для снижения младенческой смертности от врожденных пороков сердца. Методические рекомендации. М.: ФГБУ "НМИЦ ССХ им. А.Н. Бакулева" Минздрава России; 2024: 64 с. DOI: 10.24022/978-5-7983-0461-8-2024-1-64.

197. Giglia T., Massicotte M., Tweddell J. et al. Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation. 2013; 128: 2622 - 2703.

198. Boucher AA, Heneghan JA, Jang S, Spillane KA, Abarbanell AM, Steiner ME, Meyer AD. A Narrative review of postoperative anticoagulation therapy for congenital cardiac disease. Front Surg. 2022 Jun 14; 9: 907782.

199. McCrindle BW, Michelson AD, Van Bergen AH, Suzana Horowitz E, Pablo Sandoval J, Justino H, Harris KC, Jefferies JL, Miriam Pina L, Peluso C, Nessel K, Lu W, Li JS; UNIVERSE Study Investigators *. Thromboprophylaxis for Children Post-Fontan Procedure: Insights From the UNIVERSE Study. J Am Heart Assoc. 2021 Nov 16; 10(22): e021765.

200. Roehl, S. L., & Townsend, R. J. (1982). Alprostadil (Prostin VR Pediatric Sterile Solution, the Upjohn Company). Drug Intelligence & Clinical Pharmacy, 16(11), 823 - 832.